Saturday, March 15, 2025 | 06:21 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Street signs: Gland's grey market premium shrinks, banking stocks, and more

The grey market premium for Gland Pharma has come off sharply from Rs 185 per share to just Rs 60 per share

People walk past the Bombay Stock Exchange (BSE) building in Mumbai. Photo: Reuters
Premium

People walk past the Bombay Stock Exchange (BSE) building in Mumbai. Photo: Reuters

Sundar SethuramanAshley Coutinho Thiruvananthapuram/Mumbai
Gland’s grey market premium shrinks

The grey market premium for Gland Pharma has come off sharply from Rs 185 per share to just Rs 60 per share. Market players say the company has priced its IPO aggressively which has hit sentiment in the grey market. China’s Fosun Pharma-promoted firm has set the price band at Rs 1,490-Rs 1,500 per share for its Rs 6,480-crore IPO. “Many were expecting that the issue will be price around Rs 1,300 per share,” said a broker.

Sundar Sethuraman

Much steam left in bank stock rally

The Nifty Bank index posted its biggest

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in